IRIDIUM GARZE

· Fidia Farmaceutici s.p.a.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IRIDIUM GARZE, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment [NA]